Bone Biologics Corp
BBLG· Nasdaq
BBLGBone Biologics Corp
Filed Nov 19, 2014 · 10-Q · 50 days after period end · 0001493152-14-003890
| Metric | Q3 2014 | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|---|
| Net Income | -$2.61M | -$238.22K | -$1.09K | -$725.00 |
| EPS Diluted | -$0.20 | -$0.02 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bone Biologics Corp · CIK 1419554 · Engraved from SEC EDGAR
ended Sep 30, 2014 · filed Nov 19, 2014 · 50 d after period end
